⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 13, 2024HematologyOpen Access

Circular RNA_0003489 reflects unfavorable treatment response and shortened survival in newly diagnosed multiple myeloma patients who receive bortezomib-based induction therapy

Senhua Song Junjie Xie Biao Xu Qijie Ran

View Full Paper

Ask AI

Bookmark

Share

Abstract

Circular RNA_0003489 (Circ_0003489) promotes multiple myeloma (MM) progression and bortezomib resistance in MM cells, while its potential as a biomarker in newly diagnosed MM (NDMM) patients is unclear. Thus, this study aimed to investigate the association of circ_0003489 expression with treatment response and survival in NDMM patients who received bortezomib-based induction therapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Song et al. (2024) studied this question.

synapsesocial.com/papers/68e58a5ab6db643587526112 https://doi.org/10.1080/16078454.2024.2399419

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair2024 · 8 citations
2Nanopore sequencing-based profiling of circular RNAs in multiple myeloma uncovers circNFATC3 as a promising prognostic biomarker2025 · 1 citations
3LDH-mediated autophagic full-chain blockade for Multiple Myeloma treatment by targeting circ_0008255/miR-192-5p/ATG2A axisIn Vitro Study · 2026
4Circ_0003945: an emerging biomarker and therapeutic target for human diseases2024 · 1 citations
5Myeloma-derived exosomal circ_0002724 promotes osteoclastogenesis through a miR-4753-3p/IFIT1 and RANK axis in myeloma bone diseaseOriginal Research · 2026